371 related articles for article (PubMed ID: 10470700)
1. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group.
Hermans PW; Hibberd ML; Booy R; Daramola O; Hazelzet JA; de Groot R; Levin M
Lancet; 1999 Aug; 354(9178):556-60. PubMed ID: 10470700
[TBL] [Abstract][Full Text] [Related]
2. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.
Geishofer G; Binder A; Müller M; Zöhrer B; Resch B; Müller W; Faber J; Finn A; Endler G; Mannhalter C; Zenz W;
Eur J Pediatr; 2005 Aug; 164(8):486-90. PubMed ID: 15843979
[TBL] [Abstract][Full Text] [Related]
3. 4G4G genotype of the plasminogen activator inhibitor-1 promoter polymorphism associates with disseminated intravascular coagulation in children with systemic meningococcemia.
Binder A; Endler G; Müller M; Mannhalter C; Zenz W;
J Thromb Haemost; 2007 Oct; 5(10):2049-54. PubMed ID: 17697137
[TBL] [Abstract][Full Text] [Related]
4. Role of functional plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism in susceptibility, severity, and outcome of meningococcal disease in Caucasian children.
Haralambous E; Hibberd ML; Hermans PW; Ninis N; Nadel S; Levin M
Crit Care Med; 2003 Dec; 31(12):2788-93. PubMed ID: 14668616
[TBL] [Abstract][Full Text] [Related]
5. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock.
Westendorp RG; Hottenga JJ; Slagboom PE
Lancet; 1999 Aug; 354(9178):561-3. PubMed ID: 10470701
[TBL] [Abstract][Full Text] [Related]
6. The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism.
Stegnar M; Uhrin P; Peternel P; Mavri A; Salobir-Pajnic B; Stare J; Binder BR
Thromb Haemost; 1998 May; 79(5):975-9. PubMed ID: 9609232
[TBL] [Abstract][Full Text] [Related]
7. The 4G/4G Genotype of PAI-1 Polymorphism Is Associated with Higher Plasma PAI-1 Concentrations and Mortality in Patients with Severe Sepsis.
Lorente L; Martín MM; Borreguero-León JM; Barrios Y; Solé-Violán J; Ferreres J; Labarta L; Díaz C; Jiménez A
PLoS One; 2015; 10(6):e0129565. PubMed ID: 26066833
[TBL] [Abstract][Full Text] [Related]
8. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
[TBL] [Abstract][Full Text] [Related]
9. PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects.
Seguí R; Estellés A; Mira Y; España F; Villa P; Falcó C; Vayá A; Grancha S; Ferrando F; Aznar J
Br J Haematol; 2000 Oct; 111(1):122-8. PubMed ID: 11091191
[TBL] [Abstract][Full Text] [Related]
10. Influence of PAI-1 gene promoter-675 (4G/5G) polymorphism on fibrinolytic activity after cardiac surgery employing cardiopulmonary bypass.
Ozolina A; Strike E; Jaunalksne I; Serova J; Romanova T; Zake LN; Sabelnikovs O; Vanags I
Medicina (Kaunas); 2012; 48(10):515-20. PubMed ID: 23324247
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between sepsis and 4G/5G polymorphism within the promoter region of plasminogen activator inhibitor-1 gene].
Zhan ZY; Wang HW; Chen DF; Cheng BL; Wang HH; Fang XM
Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(34):2404-7. PubMed ID: 16321247
[TBL] [Abstract][Full Text] [Related]
12. The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.
Pérez-Martínez P; Adarraga-Cansino MD; Fernández de la Puebla RA; Blanco-Molina A; Delgado-Lista J; Marín C; Ordovás JM; López-Miranda J; Pérez-Jiménez F
Br J Nutr; 2008 Apr; 99(4):699-702. PubMed ID: 17903340
[TBL] [Abstract][Full Text] [Related]
13. Association of plasminogen activator inhibitor-1 gene polymorphism and type 2 diabetic nephropathy.
Xu F; Liu H; Sun Y
Ren Fail; 2016; 38(1):157-62. PubMed ID: 26616527
[TBL] [Abstract][Full Text] [Related]
14. PAI-1 4G/5G insertion/deletion promoter polymorphism and microvascular complications in type 2 diabetes mellitus.
Funk M; Endler G; Exner M; Marculescu R; Endler L; Abrahamian H; Mauler H; Grimm A; Raith M; Mannhalter C; Prager R; Irsigler K; Wagner OF
Wien Klin Wochenschr; 2005 Oct; 117(19-20):707-10. PubMed ID: 16416371
[TBL] [Abstract][Full Text] [Related]
15. Promotor polymorphisms of plasminogen activator inhibitor-1 and other thrombophilic genotypes in cerebral venous thrombosis: a case-control study in adults.
Ringelstein M; Jung A; Berger K; Stoll M; Madlener K; Klötzsch C; Schlachetzki F; Stolz E
J Neurol; 2012 Nov; 259(11):2287-92. PubMed ID: 22527222
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography.
Ossei-Gerning N; Mansfield MW; Stickland MH; Wilson IJ; Grant PJ
Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):33-7. PubMed ID: 9012634
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
[TBL] [Abstract][Full Text] [Related]
18. Contribution of the type 1 plasminogen activator inhibitor 4G/5G gene polymorphism to impaired fibrinolysis in vital exhaustion.
von Känel R; Maly FE; Frey K; Fischer JE
Ital Heart J; 2003 Nov; 4(11):791-6. PubMed ID: 14699709
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients.
Menges T; Hermans PW; Little SG; Langefeld T; Böning O; Engel J; Sluijter M; de Groot R; Hempelmann G
Lancet; 2001 Apr; 357(9262):1096-7. PubMed ID: 11297964
[TBL] [Abstract][Full Text] [Related]
20. 4G/5G Polymorphism of the plasminogen activator inhibitor-1 gene is associated with multiple organ dysfunction in critically ill patients.
Huq MA; Takeyama N; Harada M; Miki Y; Takeuchi A; Inoue S; Nakagawa T; Kanou H; Hirakawa A; Noguchi H
Acta Haematol; 2012; 127(2):72-80. PubMed ID: 22134139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]